This invention concerns a process to convert a hydroxyl group (bold in R
3
C—OH) in a tigliane-type compound to a hydrogen (bold in R
3
C—H) to obtain deoxytigliane-type compounds or structural or functional analogs thereof. The process has wide application particularly to produce specific biologically active compounds in quantity for use as pharmaceuticals. In particular the process can be used to convert phorbol to a 12-deoxytigliane (prostrating which is a therapeutic lead for the treatment of AIDS. New compositions of matter are also disclosed.
这项发明涉及一种将
蒽醌型化合物中的一个羟基(在R3C—OH中加粗)转化为氢(在R3C—H中加粗),以获得脱氧
蒽醌型化合物或其结构或功能类似物的过程。该过程具有广泛的应用,特别是用于大量生产特定
生物活性化合物,以用作药物。具体而言,该过程可用于将富尔
酚转化为12-脱氧
蒽醌(俯卧的,用于治疗艾滋病的治疗前导物)。还公开了新的物质组合。